Ayat H. Zagzoog
Prince Albert, SK, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
An improved method for quantification of cannabidiol, Δ9-tetrahydrocannabinol, and their metabolites in human plasma and urine.
Journal: Journal of pharmaceutical and biomedical analysis
Published: January 07, 2026
Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1.
Journal: Communications chemistry
Published: September 20, 2025
Pharmacokinetics and pharmacodynamics of cannabigerol (CBG) in the C57BL/6Crl mouse.
Journal: Frontiers in pharmacology
Published: July 23, 2025
In vitro pharmacological activity of twenty-eight synthetic cannabinoid receptor agonists at the type 1 and 2 cannabinoid receptors.
Journal: Neurochemistry international
Published: July 03, 2025
Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study.
Journal: ACS chemical neuroscience
Published: January 15, 2025
The Intoxication Equivalency of 11-Hydroxy-Δ9-Tetrahydrocannabinol Relative to Δ9-Tetrahydrocannabinol.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 30, 2023
Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
Journal: Scientific reports
Published: June 16, 2023
Molecular and cellular mechanisms underlying brain region-specific endocannabinoid system modulation by estradiol across the rodent estrus cycle.
Journal: Progress in molecular biology and translational science
Published: January 27, 2023
Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress.
Journal: Brain sciences
Published: December 28, 2022
Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules.
Journal: Frontiers in pharmacology
Published: May 29, 2022
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593.
Journal: Frontiers in pharmacology
Published: April 13, 2022
Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes.
Journal: Pharmacology research & perspectives
Published: March 09, 2022
Last Updated: 09/26/2026